Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127044971 | 12704497 | 1 | I | 20160822 | 20160831 | 20160831 | EXP | DK-FRESENIUS KABI-FK201605961 | FRESENIUS KABI | ANDERSEN N,BOYSEN A,ROSSEN P,SAFWAT A. BILATERAL AVASCULAR NECROSIS OF THE FEMORAL HEAD FOLLOWING TREATMENT OF EWING^S SARCOMA.. ACTA-ONCOL 2016;55(6):792-795. | 28.00 | YR | M | Y | 0.00000 | 20160831 | OT | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127044971 | 12704497 | 1 | PS | DOXORUBICIN (Manufacturer Unknown) | DOXORUBICIN | 1 | Unknown | U | 63277 | 20 | MG/M**2 | UNKNOWN | |||||||
| 127044971 | 12704497 | 2 | SS | ETOPOSIDE (Manufacturer Unknown) | ETOPOSIDE | 1 | Unknown | U | 74983 | 150 | MG/M**2 | UNKNOWN | |||||||
| 127044971 | 12704497 | 3 | SS | IRINOTECAN (Manufacturer unknown) | IRINOTECAN | 1 | Unknown | U | 77776 | 10 | MG/M**2 | UNKNOWN | |||||||
| 127044971 | 12704497 | 4 | SS | IFOSFAMIDE (Manufacturer unknown) | IFOSFAMIDE | 1 | Unknown | U | 76078 | 3 | MG/M**2 | UNKNOWN | |||||||
| 127044971 | 12704497 | 5 | SS | VINCRISTINE (manufacturer unknown) | VINCRISTINE | 1 | Unknown | U | 0 | 1.5 | MG/M**2 | UNKNOWN | |||||||
| 127044971 | 12704497 | 6 | SS | TEMOZOLOMIDE (MANUFACTURER UNKNOWN) (TEMOZOLOMIDE) (TEMOZOLOMIDE) | TEMOZOLOMIDE | 1 | Unknown | U | 0 | 100 | MG/M**2 | UNKNOWN | |||||||
| 127044971 | 12704497 | 7 | SS | ACTINOMYCIN D | DACTINOMYCIN | 1 | 0 | .75 | MG/M**2 | ||||||||||
| 127044971 | 12704497 | 8 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127044971 | 12704497 | 1 | Ewing's sarcoma |
| 127044971 | 12704497 | 2 | Ewing's sarcoma |
| 127044971 | 12704497 | 3 | Ewing's sarcoma |
| 127044971 | 12704497 | 4 | Ewing's sarcoma |
| 127044971 | 12704497 | 5 | Ewing's sarcoma |
| 127044971 | 12704497 | 6 | Ewing's sarcoma |
| 127044971 | 12704497 | 7 | Ewing's sarcoma |
| 127044971 | 12704497 | 8 | Ewing's sarcoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127044971 | 12704497 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127044971 | 12704497 | Ewing's sarcoma metastatic | |
| 127044971 | 12704497 | Malignant neoplasm progression | |
| 127044971 | 12704497 | Osteonecrosis | |
| 127044971 | 12704497 | Renal impairment | |
| 127044971 | 12704497 | Tumour necrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |